Financials
- Market Capitalization 860.77 M
- Employee 423
- Founded 2002
- CEO N/A
- Website www.collegiumpharma.com
- Headquarter Virginia, United States
- FIGI BBG000N7LPW4
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2435 | PCRX Pacira BioSciences, Inc. - Common Stock | 25.65 USD | -0.70% | +7.91% | -4.29% | +17.50% | 1.02 B USD | ||
| 2503 | AMPH Amphastar Pharmaceuticals, Inc. - Common Stock | 21.85 USD | -0.14% | -0.41% | +7.95% | -10.38% | 929.45 M USD | ||
| 2708 | EVO Evotec SE - American Depositary Shares each representing 1/2 of | 1.91 USD | -3.05% | -2.05% | -3.05% | -55.27% | 679.12 M USD | ||
| 2718 | IRWD Ironwood Pharmaceuticals, Inc. - Class A Common Stock | 4.12 USD | -2.83% | -2.60% | +8.42% | +212.12% | 680.79 M USD |
Frequently asked questions about Collegium Pharmaceutical, Inc. Common Stock
What is the Collegium Pharmaceutical, Inc. Common Stock stock price today?
The current price of Collegium Pharmaceutical, Inc. Common Stock (COLL) is 26.44. Over the past 24 hours, the stock has changed by +0.15%. Follow the COLL chart for real-time price dynamics.
What is the stock ticker of Collegium Pharmaceutical, Inc. Common Stock?
Collegium Pharmaceutical, Inc. Common Stock trades under the ticker COLL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Collegium Pharmaceutical, Inc. Common Stock stock going up?
COLL has changed by -2.97% over the last week, -26.47% over the last month, and -24.76% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Collegium Pharmaceutical, Inc. Common Stock?
Collegium Pharmaceutical, Inc. Common Stock currently has a market capitalization of 860.77 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Collegium Pharmaceutical, Inc. Common Stock earnings last quarter?
Last quarter, Collegium Pharmaceutical, Inc. Common Stock reported earnings of -0.46 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Collegium Pharmaceutical, Inc. Common Stock revenue for the last quarter?
Collegium Pharmaceutical, Inc. Common Stock reported quarterly revenue of 199.88 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Collegium Pharmaceutical, Inc. Common Stock net income for the last quarter?
Collegium Pharmaceutical, Inc. Common Stock reported net income of -15.05 M for the last quarter. The previous quarter showed 14.5 M, which means net income changed by -203.83%.
How many employees does Collegium Pharmaceutical, Inc. Common Stock have?
As of the latest available data, Collegium Pharmaceutical, Inc. Common Stock has 423 employees. Workforce size can provide additional context about the company's scale and operations.
What is Collegium Pharmaceutical, Inc. Common Stock EBITDA?
Collegium Pharmaceutical, Inc. Common Stock EBITDA is 132.45 M, and its EBITDA margin is 66.27%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Collegium Pharmaceutical, Inc. Common Stock stock?
You can buy Collegium Pharmaceutical, Inc. Common Stock (COLL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Collegium Pharmaceutical, Inc. Common Stock stock?
Investing in Collegium Pharmaceutical, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the COLL chart and related analysis on metatrader.com as part of your research.